Xist loss in hematopoietic stem cells was shown to result in the development of female-specific highly aggressive myelodysplastic syndrome (MDS) and myeloproliferative neoplasm (MPN), suggesting a tumor suppressor role for Xist [5]. This evidence concerns the gene XIST and myeloproliferative neoplasm.